ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

TRX Tissue Regenix Group Plc

62.50
-0.50 (-0.79%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.79% 62.50 62.00 63.00 62.50 62.50 62.50 2,827 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 24.48M -2.7M -0.0382 -16.36 44.11M
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 63p. Over the last year, Tissue Regenix shares have traded in a share price range of 49.00p to 71.50p.

Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £44.11 million. Tissue Regenix has a price to earnings ratio (PE ratio) of -16.36.

Tissue Regenix Share Discussion Threads

Showing 8651 to 8673 of 14750 messages
Chat Pages: Latest  350  349  348  347  346  345  344  343  342  341  340  339  Older
DateSubjectAuthorDiscuss
23/5/2016
06:38
Bamboo2.
You will do very well here in the long run. I see you have bought into QP as well.Did you manage to buy into QP in the low 60P's ?
Thanks for posting the info.
ATB.

callmebwana
21/5/2016
22:38
Tissue Regenix Group plc, officially opens new Leeds site...
bamboo2
20/5/2016
15:29
results monday.
knights
18/5/2016
08:52
Re, last weeks large share transaction.

It does seem somewhat odd that we have not yet had a holdings RNS

bamboo2
14/5/2016
09:50
The German partnership should start producing income next year. I found this document, with a summary of the tie-up.
bamboo2
11/5/2016
20:46
Ballie Gifford & Co Ltd hold or maybe held about 5%
bamboo2
11/5/2016
15:59
Looks more like a sell to me. Why would it keep dribbling down on buys? Doesn't seem like optimism is rife here. Anyway, we need some news.
rayrac
11/5/2016
10:42
That's near 5% of the company, so we'll soon find out from an RNS.
igbertsponk
11/5/2016
10:03
Has Mr Woodford just added ?? 36,666,667 @18.5p - All the recent 18.5p's have been buys !!
channel pirate
06/5/2016
09:51
Hmmm, the question is AndrewB, how much more is this going to dip !! I personally bought a few more at 19.25p when it dipped, but it looks like it is still dipping. Anyway, I still feel comfortable holding, especially as Mr W. was still buying recently at 20.25p
channel pirate
03/5/2016
11:10
Close Asset Management sold 3.89 million prior to 4 April, leaving 3.47 million; so perhaps it's still selling; but others have been buying in the same period, so I don't feel there's a problem. Good time to take a position or picking up a few more on the dip.
andrewbaker
03/5/2016
09:22
Regarding today's drop - maybe Mr Woodford has asked the mm's if they can gather a few more shares for him !!
channel pirate
26/4/2016
13:56
The advert looks fine to me, I was able to follow it ok.

Key to the product's success is the speed of cell migration and vascularisation of the graft. I'm not a doctor, but I understand the principles of wound healing. I think the advert will be easy for medical professionals to take in.

karmicpete
26/4/2016
06:15
horneblower, it was part of the SAWC publicity.
Presume directed at surgeons, clinicians and other woundcare profs.
I know what you mean about the speed of the graphics but guess if you are familiar with the terminology, it's not a problem. TRX produce the best ECM's in the world.

bamboo2
25/4/2016
21:12
Hmm.

Who is this directed at?
How much did it cost?
Why is some of the most important text flashed up too quick to be read?

'Fraid I'm not impressed.

Hopefully the actual product is better than this ad.

horneblower
20/4/2016
06:51
20 April 2016

Tissue Regenix Group plc

Notice of Preliminary Results

Leeds, 20th April 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group"), the regenerative medical devices company, announces that it will publish its unaudited preliminary results for the year ended 31(st) January 2016, on Monday 23(rd) May 2016.

A results presentation will be held on the morning of the 23(rd) May in London, with corporate and financial updates from CEO Antony Odell, and CFO, Ian Jefferson, as well as guest speaker Dr Francisco da Costa from The Groups research partner, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.

bamboo2
15/4/2016
07:41
SAWC on this week in the US.
bamboo2
14/4/2016
11:55
May not sound as desres but clearly more practical and fit for purpose. I'd be happy with a little retrace here to give me time to assemble some funds for another top up.
luminoso
14/4/2016
07:36
luminoso, This move has happened over the last year or so.

Ex Leeds Uni students who stay in the area will provide a useful pool of potential staff for the new labs. These are people who will have been taught by Eileen Ingham etc, so will have learnt the dCell process from the boss!



14 April 2016

Tissue Regenix Group plc

Change of Registered Office

Leeds, 14(th) April 2016 - Tissue Regenix Group (AIM:TRX) ("Tissue Regenix" or "The Group") the regenerative medical devices company announces that the Company's Registered Office address has changed from The Biocentre, Innovation Way, Heslington, York, YO10 5NY to: Unit 1 & 2, Astley Way, Astley Lane Industrial Estate, Swillington, Leeds LS26 8XT with immediate effect.

bamboo2
14/4/2016
07:21
Moved from York to Leeds. New address does not have the ring of "Innovation Way"!
luminoso
10/4/2016
17:55
Forms for Clinical Evaluation of dCELL® ACL Scaffold for Reconstruction of the Anterior Cruciate Ligament



Still very few direct competitors, for Dermapure



Most of these alternatives are not derived from dermis, but from amniotic, placental or other material. Some are from dermis, but are cryogenically preserved, meaning defrost hassle. Others look like they go beyond the description of minimal manipulation.

bamboo2
06/4/2016
16:31
Looks like we may have a 'proper'* Golden Cross on the chart in the next few days.
*= 50sma crosses a rising 200sma.

bamboo2
30/3/2016
22:12
Later in the same meeting, Francisco da Costa was awarded the Jeffrey Borer Heart Valve Outcomes Abstract Award.
bamboo2
Chat Pages: Latest  350  349  348  347  346  345  344  343  342  341  340  339  Older

Your Recent History

Delayed Upgrade Clock